Haresign Consulting Services

Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23

Published

11 May 2026

Source

Alerts and Recalls for Drugs and Medical Devices - All

Imported

6 Jun 2026

Original alert

https://www.gov.uk/drug-device-alerts/c…

Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.

View Original Alert

Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.

About this source

Alerts and Recalls for Drugs and Medical Devices - All

All alerts from this source

Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.

View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.